Converging on cancer at the nanoscale
Marking its first anniversary, the Koch Institute’s Marble Center for Cancer Nanomedicine goes full steam ahead.
Marking its first anniversary, the Koch Institute’s Marble Center for Cancer Nanomedicine goes full steam ahead.
Biologists discover the immune system can eliminate cells with too many or too few chromosomes.
Findings support new strategy of continuous drug delivery by implantable device.
Blocking the transition to a more aggressive state could offer a new treatment strategy.
Senior Tiffany Yeh explores health care and poverty through working abroad, and cultivates her love of music while at home.
Introducing genetic mutations with CRISPR offers a fast and accurate way to simulate the disease.
Hadley Sikes is bridging the gap between engineering and public policy to solve big social problems at home and abroad.
Koch Institute director advocates support for biomedical research in testimony before the House Committee on Oversight and Government Reform.
“Synthetic biomarkers” could be used to diagnose ovarian cancer months earlier than now possible.
Differences in chromosome number may underlie variation among genetically identical individuals.
Microfluidic device isolates plasma cells from blood rather than bone marrow.
Researchers program RNA nanoparticles that could protect against the virus.
New technique can reveal exposure to aflatoxin, a potent carcinogen, before tumors develop.
New strategy could improve performance of some immune-based drugs.
Expert on long-lived rodents provides insights into research on longevity and cancer resistance.